Martín-Serrano Ángela, Gonzalez-Morena Juan M, Barbero Nekane, Ariza Adriana, Sánchez Gómez Francisco J, Pérez-Inestrosa Ezequiel, Pérez-Sala Dolores, Torres Maria J, Montañez María I
Allergy Research Group, Instituto de Investigación Biomédica de Málaga-IBIMA, Málaga, Spain.
Centro Andaluz de Nanomedicina y Biotecnología-BIONAND, Málaga, Spain.
Front Pharmacol. 2020 Nov 18;11:594755. doi: 10.3389/fphar.2020.594755. eCollection 2020.
Clavulanic acid (CLV) and amoxicillin, frequently administered in combination, can be independently involved in allergic reactions. Protein haptenation with β-lactams is considered necessary to activate the immune system. The aim of this study was to assess the suitability of biotinylated analogues of CLV as probes to study protein haptenation by this β-lactam. Two synthetic approaches afforded the labeling of CLV through esterification of its carboxylic group with a biotin moiety, via either direct binding (CLV-B) or tetraethylenglycol linker (CLV-TEG-B). The second analogue offered advantages as solubility in aqueous solution and potential lower steric hindrance for both intended interactions, with the protein and with avidin. NMR reactivity studies showed that both CLV and CLV-TEG-B reacts through β-lactam ring opening by aliphatic amino nitrogen, however with different stability of resulting conjugates. Unlike CLV conjugates, that promoted the decomposition of clavulanate fragment, the conjugates obtained with the CLV-TEG-B remained linked, as a whole structure including biotin, to nucleophile and showed a better stability. This was a desired key feature to allow CLV-TEG-B conjugated protein detection at great sensitivity. We have used biotin detection and mass spectrometry (MS) to detect the haptenation of human serum albumin (HSA) and human serum proteins. MS of conjugates showed that HSA could be modified by CLV-TEG-B. Remarkably, HSA preincubation with CLV excess only reduced moderately the incorporation of CLV-TEG-B, which could be attributed to different protein interferences. The CLV-TEG-B fragment with opened β-lactam was detected bound to the HSA peptide of the treated protein. Incubation of human serum with CLV-TEG-B resulted in the haptenation of several proteins that were identified by 2D-electrophoresis and peptide mass fingerprinting as HSA, haptoglobin, and heavy and light chains of immunoglobulins. Taken together, our results show that tagged-CLV keeps some of the CLV features. Moreover, although we observe a different behavior in the conjugate stability and in the site of protein modification, the similar reactivity indicates that it could constitute a valuable tool to identify protein targets for haptenation by CLV with high sensitivity to get insights into the activation of the immune system by CLV and mechanisms involved in β-lactams allergy.
克拉维酸(CLV)和阿莫西林常联合使用,二者均可独立引发过敏反应。β-内酰胺与蛋白质形成半抗原被认为是激活免疫系统的必要条件。本研究旨在评估CLV的生物素化类似物作为研究该β-内酰胺与蛋白质形成半抗原的探针的适用性。两种合成方法通过将CLV的羧基与生物素部分进行酯化反应来标记CLV,一种是直接结合(CLV-B),另一种是通过四甘醇连接子(CLV-TEG-B)。第二种类似物具有优势,在水溶液中有较好的溶解性,并且对于与蛋白质及抗生物素蛋白的两种预期相互作用而言可能具有较低的空间位阻。核磁共振反应性研究表明,CLV和CLV-TEG-B均通过脂肪族氨基氮开环β-内酰胺环发生反应,然而生成的共轭物稳定性不同。与促进克拉维酸片段分解的CLV共轭物不同,用CLV-TEG-B获得的共轭物作为包括生物素的整体结构与亲核试剂保持连接,并且表现出更好的稳定性。这是实现高灵敏度检测CLV-TEG-B共轭蛋白的一个关键特性。我们已使用生物素检测和质谱法(MS)来检测人血清白蛋白(HSA)和人血清蛋白的半抗原化。共轭物的质谱分析表明HSA可被CLV-TEG-B修饰。值得注意的是,HSA与过量CLV预孵育仅适度降低了CLV-TEG-B的掺入,这可能归因于不同的蛋白质干扰。检测到开环β-内酰胺的CLV-TEG-B片段与处理后蛋白质的HSA肽段结合。用CLV-TEG-B与人血清孵育导致几种蛋白质发生半抗原化,通过二维电泳和肽质量指纹图谱鉴定为HSA、触珠蛋白以及免疫球蛋白的重链和轻链。综上所述,我们的结果表明标记的CLV保留了CLV的一些特性。此外,尽管我们观察到共轭物稳定性和蛋白质修饰位点存在不同行为,但相似的反应性表明它可能是一种有价值的工具,可用于以高灵敏度鉴定CLV形成半抗原的蛋白质靶点,从而深入了解CLV激活免疫系统的机制以及β-内酰胺过敏所涉及的机制。